Authors:
Goodkin, K
Baldewicz, TT
Asthana, D
Khamis, I
Blaney, NT
Kumar, M
Burkhalter, JE
Leeds, B
Shapshak, P
Citation: K. Goodkin et al., A bereavement support group intervention affects plasma burden of human immunodeficiency virus type 1 - Report of a randomized controlled trial, J HUMAN VIR, 4(1), 2001, pp. 44-54
Authors:
Goodkin, K
Baldewicz, TT
Wilkie, FL
Tyll, MD
Shapshak, P
Citation: K. Goodkin et al., HIV-1 infection of the brain: A region-specific approach to its neuropathophysiology and therapeutic prospects, PSYCHIAT AN, 31(3), 2001, pp. 182-192
Authors:
Shapshak, P
Fujimura, RK
Page, JB
Segal, D
Rivers, JE
Yang, J
Shah, SM
Graham, G
Metsch, L
Weatherby, N
Chitwood, DD
McCoy, CB
Citation: P. Shapshak et al., HIV-1 RNA load in needles/syringes from shooting galleries in Miami: a preliminary laboratory report, DRUG AL DEP, 58(1-2), 2000, pp. 153-157
Citation: Dm. Segal et al., Oxandrolone, used for treatment of wasting disease in HIV-1-infected patients, does not diminish the antiviral activity of deoxynucleoside analogues in lymphocyte and macrophage cell cultures, J ACQ IMM D, 20(3), 1999, pp. 215-219
Authors:
Goodkin, K
Shapshak, P
Fujimura, RK
Tuttle, RS
Bradley, WG
Yoshioka, M
Nagano, I
Xin, KQ
Kumar, A
Kumar, M
Baldewicz, TT
Maher, KJ
Asthana, D
Fletcher, MA
Citation: K. Goodkin et al., Immune function, brain, and HIV-1 infection, PROG PSYCH, (59), 1999, pp. 243-315
Authors:
Goodkin, K
Tuttle, RS
Blaney, NT
Feaster, DJ
Baldewicz, TT
Uselmann, M
Nelson, RH
Baum, MK
Shapshak, P
Kumar, M
Fletcher, MA
Citation: K. Goodkin et al., Bereavement, immunity, and the impact of bereavement support groups in HIV-1 infection, PROG PSYCH, (59), 1999, pp. 357-393